Gemcitabine-Cisplatin Chemotherapy Induces Nectin-4 Downregulation and Enfortumab Vedotin Resistance in Bladder Cancer
- DOI
- 10.1016/j.euo.2026.08.003
- Published
- 2026-09
- Container
- European Urology Oncology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.euo.2026.08.003,
title = {Gemcitabine-Cisplatin Chemotherapy Induces Nectin-4 Downregulation and Enfortumab Vedotin Resistance in Bladder Cancer},
author = {Christoph Nössing and Isabella Prantl and Reinhard Grausenburger and Iris E. Ertl and Ursula Lemberger and Paula Herek and Luis Rupp and Agata Suleja and Oliver Baumfried and Jule Schrimpf and Christine Pirker and Anna Koren and Stefan Kubicek and Eva Compérat and Markus Eckstein and Walter Berger and Shahrokh F. Shariat and Bernhard Englinger},
year = {2026},
journal = {European Urology Oncology},
doi = {10.1016/j.euo.2026.08.003},
url = {https://doi.org/10.1016/j.euo.2026.08.003}
}RIS
TY - JOUR TI - Gemcitabine-Cisplatin Chemotherapy Induces Nectin-4 Downregulation and Enfortumab Vedotin Resistance in Bladder Cancer AU - Christoph Nössing AU - Isabella Prantl AU - Reinhard Grausenburger AU - Iris E. Ertl AU - Ursula Lemberger AU - Paula Herek AU - Luis Rupp AU - Agata Suleja AU - Oliver Baumfried AU - Jule Schrimpf AU - Christine Pirker AU - Anna Koren AU - Stefan Kubicek AU - Eva Compérat AU - Markus Eckstein AU - Walter Berger AU - Shahrokh F. Shariat AU - Bernhard Englinger PY - 2026 JO - European Urology Oncology DO - 10.1016/j.euo.2026.08.003 UR - https://doi.org/10.1016/j.euo.2026.08.003 ER -
APA
Nössing, C., Prantl, I., Grausenburger, R., Ertl, I. E., Lemberger, U., Herek, P., Rupp, L., Suleja, A., Baumfried, O., Schrimpf, J., Pirker, C., Koren, A., Kubicek, S., Compérat, E., Eckstein, M., Berger, W., Shariat, S. F., & Englinger, B. (2026). Gemcitabine-Cisplatin Chemotherapy Induces Nectin-4 Downregulation and Enfortumab Vedotin Resistance in Bladder Cancer. European Urology Oncology. https://doi.org/10.1016/j.euo.2026.08.003
Source records
- crossref · retrieved 2026-09-25T12:12:08.559Z